{"id":31387,"date":"2023-12-11T11:29:11","date_gmt":"2023-12-11T11:29:11","guid":{"rendered":"https:\/\/cells4life.com\/?p=31387"},"modified":"2025-11-26T15:22:31","modified_gmt":"2025-11-26T15:22:31","slug":"encouraging-early-stage-trial-for-ms-stem-cell-therapy","status":"publish","type":"post","link":"https:\/\/cells4life.com\/us\/2023\/12\/encouraging-early-stage-trial-for-ms-stem-cell-therapy\/","title":{"rendered":"Encouraging Signs For MS Stem Cell Therapy In Early-Stage of Trial"},"content":{"rendered":"[et_pb_section fb_built=”1″ _builder_version=”4.16″ global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.27.4″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]\n

The first phase of a clinical trial hoping to treat Multiple sclerosis (MS) with stem cells has yielded promising results.\u00a0<\/span><\/p>\n

The early-stage trial was conducted by researchers <\/span>at the University of Cambridge, along with scientists from the University of Milan Bicocca and La Casa Sollievo della Sofferenza hospital in Italy. [1]<\/a>\u00a0<\/span><\/p>\n

The trial involved injecting stem cells into the brains of 15 MS patients in an attempt to halt the spread of the disease.\u00a0<\/span><\/p>\n

Researchers found that the potential treatment was both well tolerated by the patients and that it protected the brain from further damage.<\/span><\/p>\n

 <\/p>\n

What is Multiple sclerosis?\u00a0\u00a0<\/span><\/h3>\n

Multiple sclerosis is a chronic neuroinflammatory condition, meaning that it mistakenly attacks healthy parts of the body as a result of problems with the immune system.\u00a0<\/span><\/p>\n

MS predominantly affects the brain and spinal cord and can cause a wide range of symptoms, including problems with mobility, vision, sensation and balance. [2]<\/a><\/span><\/p>\n

The condition affects approximately 1,000,000 people over the age of 18 in the United States with 10,000 new cases diagnosed each year. [3]<\/a>\u00a0<\/span><\/p>\n

 <\/p>\n

How does the treatment work?<\/span><\/h3>\n

In the early-phase trial, the results of which were published in the journal <\/span>Cell Stem Cell<\/span><\/i><\/a>, researchers injected between 5 million and 24 million neural stem cells (NSCs) into the brains of 15 patients with secondary progressive MS.\u00a0<\/span><\/p>\n

Because one of the core drivers of MS proliferation is the inflammation of myeloid cells – cells that make up the first defence of the immune system – the NSCs are designed to reduce inflammation, rather than rebuild tissue as in the majority of stem cell treatments.\u00a0<\/span><\/p>\n

In reducing the inflammation of the myeloid cells, the NSCs have the potential to slow and perhaps even prevent any further progression in the severity of the patients\u2019 conditions.<\/span><\/p>\n

 <\/p>\n

What were the results?<\/span><\/h3>\n

There were no deaths or adverse effects reported in the patients. Although one patient did experience a steroid-induced psychosis one month after treatment, they made a full recovery.\u00a0\u00a0<\/span><\/p>\n

Overall, the treatment was deemed to be both safe and well-tolerated by the patients, although the scientists involved admit that results were limited due to the small size of the study.\u00a0<\/span><\/p>\n

They hope further, larger-scale trials will follow so that they can determine whether this treatment truly has the capability to alter the course of the progression of MS.\u00a0<\/span><\/p>\n

 <\/p>\n

For more information<\/a> about how you can give your baby access to the future of medicine by storing their stem cells, request your FREE Info Kit now!\u00a0<\/span><\/p>\n

Sign up by using the form below.<\/span><\/p>\n

 <\/p>\n

Sources<\/strong><\/p>\n

[1] ‘Doctors encouraged by early-stage trial of MS stem cell therapy’, 27 November, 2023, The Guardian<\/a><\/p>\n

[2] NHS Website<\/a><\/p>\n

[3] American Brain Foundation<\/a><\/p>\n[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ module_class=”down-arrow” _builder_version=”4.27.4″ background_color=”#bd144f” custom_padding=”0px|||” locked=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text admin_label=”RWP” module_id=”request-welcome-pack” _builder_version=”4.27.4″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” background_layout=”dark” use_border_color=”off” global_colors_info=”{}”]\n

FIND OUT MORE, REQUEST YOUR FREE INFO KIT TODAY<\/h3>\n

All you need to know to make an informed decision.<\/p>\n

Provide your contact details to request:<\/p>\n

– Complete Info Kit and your Guide to Cord Blood Banking
– Information via email
– Contact from our specialist advisors<\/p>\n

 <\/p>\n\n

\n

<\/p>